We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,911 results
  1. Comparative evaluation of bioactive phytochemicals in Spinacia oleracea cultivated under greenhouse and open field conditions

    Various factors related to growing conditions can influence the nutritional quality of plants, including vegetable crops, especially the contents of...

    Bum Soo Lee, Hae Min So, ... Ki Hyun Kim in Archives of Pharmacal Research
    Article 19 November 2022
  2. Effects of chronic delta-opioid receptor agonist on the excitability of hippocampal glutamate and brainstem monoamine neurons, anxiety, locomotion, and habituation in rats

    Background

    Short-term treatment with non-peptide agonists of delta-opioid receptors, such as agonist SNC80, induced behavioral effects in rodents,...

    Eliyahu Dremencov, Daniil Grinchii, ... Daniela Jezova in Pharmacological Reports
    Article 15 April 2023
  3. Effect of Thioxypine and Its Components on Behavioral Despair in Potential Antidepressant Screening Tests

    The effect of thioxypine (2-ethyl-6-methylpyridinol-3-yl thioctate) and its acyl and alcohol components on the duration of behavioral despair (BD) in...

    I. A. Volchegorskii, I. Y. Miroshnichenko, ... R. R. Mihajlov in Pharmaceutical Chemistry Journal
    Article 01 January 2024
  4. Uliginosin B, a Natural Phloroglucinol, Increases Hippocampal GSH, MCP-1 and IL-10 Levels in Mice

    The activation of immuno-inflammatory pathways and oxidative/nitrosative stress results in behavioral, neurochemical, and neuroendocrine...

    Caroline Guerra Marangon, Camila Schafer Rojas, ... Stela Maris Kuze Rates in Revista Brasileira de Farmacognosia
    Article 12 September 2023
  5. Cordia dichotoma Fruits Aqueous Extracts Alleviates Depressive-Like Behavior in a Rat Model via Regulating Serotonergic Neurotransmitters

    Depression is a common mental illness caused by the interaction of social, psychological, and physical factors. The number of people suffering from...

    Zulifeiya Wusiman, Haliya Tuerxunmaimaiti, ... Maiwulanijiang Yizibula in Revista Brasileira de Farmacognosia
    Article 11 November 2023
  6. Tryptamine Analogs as Antidepressant and Anxiolytic Agents: Synthesis and In Vivo Evaluation

    A series of tryptamine derivatives were synthesized by targeting amine of tryptamine side chain with various substituted/unsubstituted phenacyl,...

    Saira Asghar, Nousheen Mushtaq, ... Zafar Saeed Saify in Pharmaceutical Chemistry Journal
    Article 18 October 2022
  7. Ameliorative Effects of Alkaloids from Narcissus cv. Hawera: Behavioral Changes Following Acute and Accelerated Chronic Restraint Stress

    The adverse effects of stress explain the increased demand for phytochemical and biochemical pharmacological agents with potential adaptogenic...

    Daniela Pechlivanova, Petar Grozdanov, ... Strahil Berkov in Revista Brasileira de Farmacognosia
    Article 26 September 2023
  8. Medication supply chain resilience during disasters: exploration of causes, strategies, and consequences applying Strauss and Corbin's approach to the grounded theory

    Background

    Due to the importance of procurement of medicines and medical supplies during disasters and the significance of an existing resilient...

    Peivand Bastani, Omid Sadeghkhani, ... Ramin Ravangard in Journal of Pharmaceutical Policy and Practice
    Article Open access 10 August 2023
  9. Crocin Administration Represses Depressive-Like Behaviors in Rats by Targeting the Hippocampal miRNA-99A/FKBP51/PSD-95 Level

    We investigated the role of miR-99a in regulating depressant activity by administering crocin in an animal model of chronic unpredictable mild stress...

    Wenyuan Zhang, Zicheng Liu, ... Miao He in Pharmaceutical Chemistry Journal
    Article 01 April 2024
  10. An Innovative Stress-Protective and Detoxification Substance for Reducing the Central Nervous System Effects of Alcohol Intoxication

    The search for new drugs to reduce the toxic effects of alcohol on the body is based on the creation of various pharmaceutical agents that affect the...

    T. V. Shushpanova, T. P. Novozheeva, ... E. M. Knyazeva in Pharmaceutical Chemistry Journal
    Article 01 October 2023
  11. Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect

    Background

    Vortioxetine hydrobromide (VXT), a new therapeutic option in the treatment of major depressive disorder, is a poorly soluble drug, and...

    Caroline Hermann Nodari, Natália Dalanhol De Quadros, ... Simone Gasparin Verza in Pharmacological Reports
    Article 09 September 2022
  12. Nootropic Effects of 7-Isoprenyloxycoumarin and Herniarin from Tagetes lucida on Lipopolysaccharide-Induced Neuroinflammation

    Tagetes lucida Cav., Asteraceae, is an essential cultural plant that is traditionally used to treat diseases involving inflammatory processes and is...

    Nayeli Monterrosas-Brisson, Enrique Jiménez-Ferrer, ... Maribel Herrera-Ruiz in Revista Brasileira de Farmacognosia
    Article 07 February 2024
  13. Design, Characterization and Optimization of Solid Lipid Nanoparticles of Bupropion by Using 23 Factorial Design

    Nanotechnology is emerging as a field in medicine that is expected to elicit significant therapeutic benefits. The main objective of the present...

    Nagadani Swarnalatha, Maruvajala Vidyavathi, Jammula Sandhya Rani in Pharmaceutical Chemistry Journal
    Article 28 July 2023
  14. Synthesis and Antidepressant Activity of 5-Amine-Substituted 3-Bromo-1-(1,1-Dioxothietan-3-yl)-4-Nitro-1H-Pyrazoles

    5-Amino-substituted 3-bromo-1-(1,1-dioxothietan-3-yl)-4-nitro-1 H -pyrazoles were synthesized via the reactions of...

    E. E. Klen, I. L. Nikitina, ... V. N. Pavlov in Pharmaceutical Chemistry Journal
    Article 01 November 2023
  15. Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson’s disease model

    Background

    Parkinson’s disease (PD) is a motor disorder characterized by the degeneration of dopaminergic neurons, putatively due to the accumulation...

    Anna Alwani, Katarzyna Maziarz, ... Piotr Chmielarz in Pharmacological Reports
    Article Open access 19 September 2023
  16. Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats

    Background

    Elevated brain levels of kynurenic acid (KYNA), a metabolite in the kynurenine pathway, are associated with cognitive dysfunctions, which...

    Francesca Frescura, Tibor Stark, ... Sarah Beggiato in Pharmacological Reports
    Article 24 May 2024
  17. Synthesis and Anxiolytic Activity of 9-(4-Ethylpiperazino-1-Carbonyl)Fluoren-9-OL Hydrochloride, A Structural Analog of the M-Choline Blocker Amizil

    Experiments on rats in a depressive-like state model caused by reserpine employed the elevated plus-maze and open-field tests and showed that...

    L. K. Khnychenko, E. E. Yakovleva, ... P. D. Shabanov in Pharmaceutical Chemistry Journal
    Article 22 July 2021
  18. Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice

    Background

    Methylphenidate and atomoxetine are used for the treatment of attention-deficit/hyperactivity disorder (ADHD). Our previous studies...

    Wahiba Sifeddine, Saadia Ba-M’hamed, ... Mohamed Bennis in Pharmacological Reports
    Article 14 February 2023
  19. L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke

    Background

    L-proline transporter (PROT/SLC6A7) is closely associated with glutamatergic neurotransmission, where L-proline modulates the NMDA receptor...

    Gustavo Almeida Carvalho, Raphaela Almeida Chiareli, ... Mauro Cunha Xavier Pinto in Pharmacological Reports
    Article 31 January 2023
  20. Reformative Effect of Daidzein on Motor Dysfunction Following Rotenone Injection in Ovariectomized Rats

    Parkinson’sdisease is a neurodegenerative disorder manifested by progressive damage of dopaminergic neurons of the substantia nigra pars compacta...

    Aanchal Verma, Ahsas Goyal in Revista Brasileira de Farmacognosia
    Article 13 July 2022
Did you find what you were looking for? Share feedback.